Please login to the form below

Not currently logged in
Email:
Password:

stroke

This page shows the latest stroke news and features for those working in and with pharma, biotech and healthcare.

Celgene boosts CAR-T stake again with Bluebird Bio deal

Celgene boosts CAR-T stake again with Bluebird Bio deal

The firmed-up deal with Bluebird comes after Celgene completed its $9bn acquisition of CAR-T player Juno, which at a stroke gave it a major stake in the emerging cancer

Latest news

More from news
Approximately 14 fully matching, plus 509 partially matching documents found.

Latest Intelligence

  • Digital disruption in market access Digital disruption in market access

    Accession is currently working with the NHS in the UK to prevent the devastating impact of stroke caused by atrial fibrillation (AF) through the use of digital technology. ... AF strokes are likely to be the most serious strokes, cause long-term harm and

  • Is it possible to change behaviour virtually? Is it possible to change behaviour virtually?

    Clinicians' ability to identify the correct patients for different stroke prevention treatments had been identified as a barrier to optimal management of non-valvular atrial fibrillation (NVAF).

  • Delivering digital value Delivering digital value

    We will be able to record patients' data through smart-watches and remotely address their needs, track medicine adherence through smart pills, and automatically call an ambulance for a stroke through

  • Deal Watch January 2016 Deal Watch January 2016

    245. Athersys/ Healios. Licence. Development and commercialisation of cell therapy treatments including MultiStem for the treatment of ischaemic stroke.

  • Forging a path in specialty care Forging a path in specialty care

    The former, now known as Takeda Oncology, gave the company an instant presence in oncology, and the latter increased its European reach at a stroke.

More from intelligence
Approximately 0 fully matching, plus 20 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 18 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics